Tieni traccia delle ultime attività di insider trading Voyager Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Voyager Therapeutics.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Aug 20, 2025 | CHIEF MEDICAL OFFICER | -19.00K | $3.73 | -$70.87K | SELL | -12.03% | 138.91K | Aug 18 | ||
Apr 04, 2025 | CHIEF MEDICAL OFFICER | -10.09K | $3.43 | -$34.59K | SELL | -6.00% | 157.91K | Apr 02 | ||
Apr 04, 2025 | PRESIDENT AND CEO | -10.88K | $3.43 | -$37.34K | SELL | -2.46% | 430.93K | Apr 02 | ||
Feb 24, 2025 | CHIEF SCIENTIFIC OFFICER | 42.70K | $4.26 | -$14.08K | GRANT | 52.69% | 123.72K | Feb 20 - Feb 21 | ||
Feb 24, 2025 | PRESIDENT AND CEO | 133.30K | $4.24 | -$49.62K | GRANT | 43.21% | 441.82K | Feb 20 - Feb 21 | ||
Feb 24, 2025 | COO & CBO | 67.36K | $4.25 | -$16.55K | GRANT | 65.85% | 169.65K | Feb 20 - Feb 21 | ||
Feb 12, 2025 | CHIEF SCIENTIFIC OFFICER | -5.41K | $4.45 | -$24.09K | SELL | -6.26% | 81.02K | Feb 11 | ||
Feb 12, 2025 | COO & CBO | -6.95K | $4.45 | -$30.93K | SELL | -6.36% | 102.29K | Feb 11 | ||
Feb 12, 2025 | PRESIDENT & CEO | -16.64K | $4.45 | -$74.07K | SELL | -5.12% | 308.52K | Feb 11 | ||
Feb 12, 2025 | CHIEF LEGAL OFFICER | -4.36K | $4.45 | -$19.39K | SELL | -5.07% | 81.64K | Feb 11 | ||
Jan 15, 2025 | COO & CBO | -3.09K | $5.09 | -$15.71K | SELL | -2.75% | 109.24K | Jan 14 | ||
Jan 15, 2025 | CHIEF SCIENTIFIC OFFICER | -1.19K | $5.13 | -$6.11K | SELL | -1.36% | 86.44K | Jan 14 | ||
Dec 26, 2024 | COO&CBO | -6.50K | $5.65 | -$36.73K | SELL | -5.47% | 112.33K | Dec 23 | ||
Oct 03, 2024 | CHIEF LEGAL OFFICER | -6.00K | $5.82 | -$34.91K | SELL | -6.52% | 86.00K | Oct 02 | ||
Apr 03, 2024 | CHIEF OPERATING OFFICER | -1.36K | $9.88 | -$13.41K | SELL | -1.15% | 117.00K | Apr 02 | ||
Apr 03, 2024 | PRESIDENT AND CEO | -12.12K | $9.86 | -$119.45K | SELL | -3.62% | 322.84K | Apr 02 | ||
Feb 22, 2024 | CHIEF OPERATING OFFICER | -3.97K | $7.45 | -$29.55K | SELL | -3.24% | 118.36K | Feb 21 | ||
Feb 22, 2024 | PRESIDENT AND CEO | -13.03K | $7.46 | -$97.23K | SELL | -3.75% | 334.95K | Feb 21 | ||
Feb 22, 2024 | CHIEF FINANCIAL OFFICER | -3.76K | $7.46 | -$28.08K | SELL | -2.10% | 175.67K | Feb 21 | ||
Feb 22, 2024 | CHIEF SCIENTIFIC OFFICER | -3.97K | $7.50 | -$29.76K | SELL | -4.33% | 87.63K | Feb 20 - Feb 21 | ||
Jan 19, 2024 | CHIEF OPERATING OFFICER | -2.54K | $7.15 | -$18.18K | SELL | -3.40% | 72.33K | Jan 17 | ||
Jan 19, 2024 | CHIEF SCIENTIFIC OFFICER | -1.27K | $7.18 | -$9.09K | SELL | -2.33% | 53.09K | Jan 17 | ||
Oct 05, 2023 | CHIEF FINANCIAL OFFICER | -13.57K | $6.99 | -$94.83K | SELL | -8.32% | 149.43K | Oct 03 | ||
Sep 18, 2023 | CHIEF SCIENTIFIC OFFICER | -5.50K | $5.50 | -$71.43K | SELL | -9.19% | 54.36K | Sep 15 | ||
Jul 10, 2023 | CHIEF SCIENTIFIC OFFICER | -5.50K | $10.80 | -$59.40K | SELL | -8.41% | 59.86K | Jul 06 | ||
Jul 05, 2023 | CHIEF SCIENTIFIC OFFICER | 0.00 | $7.13 | -$42.80K | SELL-OPTIONS | 0.00% | 65.36K | Jun 30 | ||
Apr 05, 2023 | PRESIDENT AND CEO | -7.44K | $7.83 | -$58.23K | SELL | -3.35% | 214.62K | Apr 03 | ||
Apr 05, 2023 | CHIEF OPERATING OFFICER | -1.26K | $7.83 | -$9.86K | SELL | -1.73% | 71.62K | Apr 03 | ||
Mar 22, 2023 | CHIEF SCIENTIFIC OFFICER | -2.19K | $7.76 | -$17.02K | SELL | -3.25% | 65.36K | Mar 20 | ||
Mar 22, 2023 | CHIEF OPERATING OFFICER | -3.65K | $7.76 | -$28.36K | SELL | -4.77% | 72.88K | Mar 20 | ||
Mar 22, 2023 | SENIOR VP & GENERAL COUNSEL | -4.41K | $7.76 | -$34.22K | SELL | -4.14% | 102.20K | Mar 20 | ||
Mar 17, 2023 | CHIEF OPERATING OFFICER | -15.37K | $8.20 | -$126.06K | SELL | -16.73% | 76.53K | Mar 15 | ||
Feb 24, 2023 | 10% OWNER | 4.40M | $8.88 | $39.03M | BUY | 105.16% | 8.58M | Feb 23 | ||
Feb 22, 2023 | SENIOR VP & GENERAL COUNSEL | -3.30K | $7.45 | -$24.56K | SELL | -3.00% | 106.61K | Feb 17 | ||
Feb 22, 2023 | CHIEF SCIENTIFIC OFFICER | 33.26K | $7.45 | -$5.50K | GRANT | 97.00% | 67.55K | Feb 17 | ||
Feb 15, 2023 | CHIEF SCIENTIFIC OFFICER | -797.00 | $7.67 | -$6.11K | SELL | -2.27% | 34.29K | Feb 13 | ||
Feb 15, 2023 | SENIOR VP & GENERAL COUNSEL | -2.87K | $7.67 | -$22.00K | SELL | -2.54% | 109.91K | Feb 13 | ||
Feb 01, 2023 | 10% OWNER | -388.64K | $9.23 | -$3.59M | SELL | -7.60% | 4.72M | Jan 30 - Feb 01 | ||
Jan 31, 2023 | 10% OWNER | -50.00K | $9.02 | -$451.00K | SELL | -0.97% | 5.11M | Jan 27 | ||
Jan 26, 2023 | 10% OWNER | -150.00K | $9.25 | -$1.39M | SELL | -2.82% | 5.16M | Jan 24 - Jan 25 | ||
Jan 24, 2023 | 10% OWNER | -155.00K | $9.12 | -$1.41M | SELL | -2.84% | 5.31M | Jan 20 - Jan 23 | ||
Jan 19, 2023 | SENIOR VP & GENERAL COUNSEL | -2.19K | $9.85 | -$21.55K | SELL | -1.90% | 112.78K | Jan 17 | ||
Jan 19, 2023 | CHIEF SCIENTIFIC OFFICER | -1.11K | $9.85 | -$10.89K | SELL | -3.06% | 35.09K | Jan 17 | ||
Jan 19, 2023 | CHIEF OPERATING OFFICER | -2.19K | $9.85 | -$21.55K | SELL | -4.05% | 51.90K | Jan 17 | ||
Jan 11, 2023 | 10% OWNER | -902.40K | $7.91 | -$7.14M | SELL | -18.98% | 3.85M | Jan 09 - Jan 11 | ||
Jan 10, 2023 | CHIEF SCIENTIFIC OFFICER | 0.00 | $5.79 | -$481.12 | GRANT | 0.00% | 36.19K | Dec 31 - Jan 06 | ||
Aug 26, 2022 | 10% OWNER | -349.97K | $6.16 | -$2.16M | SELL | -6.02% | 5.47M | Aug 24 - Aug 25 | ||
Aug 18, 2022 | 10% OWNER | -128.46K | $6.04 | -$775.87K | SELL | -2.16% | 5.82M | Aug 16 | ||
Aug 16, 2022 | 10% OWNER | -483.81K | $6.10 | -$2.95M | SELL | -7.53% | 5.94M | Aug 12 - Aug 15 | ||
Jul 18, 2022 | DIRECTOR | -9.51K | $6.70 | -$63.73K | SELL | -30.39% | 21.79K | Jul 14 | ||
Jul 18, 2022 | DIRECTOR | -13.89K | $6.70 | -$93.07K | SELL | -30.73% | 31.31K | Jul 14 | ||
Jun 23, 2022 | 10% OWNER | 477.40K | $5.58 | $2.66M | BUY | 11.16% | 4.75M | Jun 21 - Jun 23 | ||
Apr 06, 2022 | CHIEF OPERATING OFFICER | -1.53K | $8.25 | -$12.60K | SELL | -2.85% | 52.06K | Apr 04 | ||
Apr 06, 2022 | SENIOR VP & GENERAL COUNSEL | -2.79K | $8.25 | -$22.98K | SELL | -2.37% | 114.96K | Apr 04 | ||
Mar 23, 2022 | CHIEF OPERATING OFFICER | -4.41K | $8.29 | -$36.60K | SELL | -7.61% | 53.59K | Mar 21 | ||
Mar 23, 2022 | SENIOR VP & GENERAL COUNSEL | -4.96K | $8.29 | -$41.10K | SELL | -4.04% | 117.75K | Mar 21 | ||
Mar 23, 2022 | VP, FINANCE | -2.65K | $8.29 | -$21.97K | SELL | -4.81% | 52.46K | Mar 21 | ||
Feb 22, 2022 | SENIOR VP & GENERAL COUNSEL | -4.10K | $3.55 | -$14.55K | SELL | -3.23% | 122.70K | Feb 17 | ||
Feb 22, 2022 | VP, FINANCE | -789.00 | $3.55 | -$2.80K | SELL | -1.41% | 55.11K | Feb 17 | ||
Feb 15, 2022 | SENIOR VP & GENERAL COUNSEL | -3.25K | $3.36 | -$10.93K | SELL | -2.50% | 126.80K | Feb 11 | ||
Feb 15, 2022 | VP, FINANCE | -361.00 | $3.36 | -$1.21K | SELL | -0.64% | 55.90K | Feb 11 | ||
Jan 14, 2022 | VP, FINANCE | -265.00 | $2.57 | -$2.43K | SELL | -0.57% | 46.26K | Dec 31 - Jan 12 | ||
May 25, 2021 | SEE REMARKS | -3.52K | $4.03 | -$14.17K | SELL | -2.83% | 120.51K | May 21 | ||
Apr 07, 2021 | SENIOR VP & GENERAL COUNSEL | 3.29K | $4.95 | $16.30K | s | 3.08% | 110.06K | Apr 05 | ||
Feb 16, 2021 | PRESIDENT & CEO | -7.98K | $7.55 | -$60.23K | SELL | -5.10% | 148.38K | Feb 11 | ||
Feb 16, 2021 | CHIEF FINANCIAL OFFICER | -3.19K | $7.55 | -$24.05K | SELL | -6.49% | 45.89K | Feb 11 | ||
Feb 16, 2021 | SENIOR VP & GENERAL COUNSEL | -3.19K | $7.55 | -$24.05K | SELL | -6.06% | 49.35K | Feb 11 | ||
Feb 16, 2021 | SEE REMARKS | -3.48K | $7.55 | -$26.24K | SELL | -6.15% | 53.02K | Feb 11 | ||
Jan 14, 2021 | PRESIDENT & CEO | -10.44K | $8.62 | -$90.02K | SELL | -6.26% | 156.35K | Jan 12 | ||
Jan 14, 2021 | CHIEF FINANCIAL OFFICER | -2.94K | $8.62 | -$25.36K | SELL | -5.66% | 49.08K | Jan 12 |
Sfoglia insider trading su tutte le azioni.